Pharming (PHAR) Operating Expenses (2020 - 2026)

Pharming's Operating Expenses history runs 7 years deep, the most recent figure standing at -$40.8 million for Q1 2026.

• Quarterly Operating Expenses rose 6.54% year-over-year to -$40.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$128.6 million (up 34.92% YoY) and the FY2025 annual result came in at $411.7 million, up 15.74% from the prior year.
• Operating Expenses was -$40.8 million for Q1 2026 at Pharming, down from -$52.1 in the prior quarter.
• Across five years, Operating Expenses topped out at -$36.0 in Q3 2024 and bottomed at -$87.8 million in Q2 2025.
• A 5-year average of -$41.0 million and a median of -$36.5 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses slumped 241.44% — and 2025, when it jumped 100.0%.
• Pharming's Operating Expenses stood at -$81.0 million in 2022, then jumped by 31.02% to -$55.9 million in 2023, then slumped by 48.8% to -$83.1 million in 2024, then soared by 100.0% to -$52.1 in 2025, then plunged by 78260936.47% to -$40.8 million in 2026.
• Business Quant data shows PHAR's Operating Expenses at -$40.8 million in Q1 2026, -$52.1 in Q4 2025, and -$40.4 in Q3 2025.